An excessive expression of NOX4 was reported in both of cardiovascular and pulmonary diseases, including atherosclerosis, pulmonary fibrosis, pulmonary hypertension, and COPD [16, 18–20]. Here, NOX4 is linked to pulmonary hypertension.